Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model

Journal of Cell Biology

Volumn 171, Issue 4, 2005, Pages 663-673

  Xian, Wa ^a   Schwertfeger, Kathryn L ^a   Vargo Gogola, Tracy ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; BETA CATENIN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; UVOMORULIN; VIMENTIN;

ANIMAL CELL; ARTICLE; BREAST EPITHELIUM; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL POLARITY; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DISSOCIATION; ENZYME INDUCTION; EPITHELIUM CELL; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BASEMENT MEMBRANE; CADHERINS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DIMERIZATION; EPITHELIAL CELLS; EPITHELIUM; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMAGING, THREE-DIMENSIONAL; IMMUNOBLOTTING; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASE 3; MESODERM; MICE; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PHENOTYPE; PLASMIDS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; WOUND HEALING;

ANIMALIA;

EID: 27944452744     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200505098     Document Type: Article

References (39)

1. Ball, R.K., R.R. Friis, C.A. Schoenenberger, W. Doppler, and B. Groner. 1988. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7:2089-2095.
2. Bates, R.C., and A.M. Mercurio. 2005. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol. Ther. 4:365-370.
3. Berx, G., A.M. Cleton-Jansen, K. Strumane, W.J. de Leeuw, F. Nollet, F. van Roy, and C. Cornelisse. 1996. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene. 13:1919-1925.
4. Birchmeier, W., and C. Birchmeier. 1995. Epithelial-mesenchymal transitions in development and tumor progression. EXS. 74:1-15.
5. Bracke, M.E., F.M. Van Roy, and M.M. Mareel. 1996. The E-cadherin/catenin complex in invasion and metastasis. Curr. Top. Microbiol. Immunol. 213:123-161.
6. Ciruna, B., and J. Rossant. 2001. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev. Cell. 1:37-49.
7. Ciruna, B.G., L. Schwartz, K. Harpal, T.P. Yamaguchi, and J. Rossant. 1997. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development. 124:2829-2841.
8. Dailey, L., D. Ambrosetti, A. Mansukhani, and C. Basilico. 2005. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16:233-247.
9. Debnath, J., S.K. Muthuswamy, and J.S. Brugge. 2003a. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in threedimensional basement membrane cultures. Methods. 30:256-268.
10. Debnath, J., S.J. Walker, and J.S. Brugge. 2003b. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. J. Cell Biol. 163:315-326.
11. Dickson, C., B. Spencer-Dene, C. Dillon, and V. Fantl. 2000. Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res. 2:191-196.
12. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer. 2:161-174.
13. Grose, R., and C. Dickson. 2005. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 16:179-186.
14. Hanafusa, H., S. Torii, T. Yasunaga, and E. Nishida. 2002. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4:850-858.
15. Herrenknecht, K., M. Ozawa, C. Eckerskorn, F. Lottspeich, M. Lenter, and R. Kemler. 1991. The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. Proc. Natl. Acad. Sci. USA. 88:9156-9160.
16. Kovalenko, D., X. Yang, R.J. Nadeau, L.K. Harkins, and R. Friesel. 2003. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation. J. Biol. Chem. 278:14087-14091.
17. Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402-408.
18. Lochter, A., S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol. 139:1861-1872.
19. McCrea, P.D., and B.M. Gumbiner. 1991. Purification of a 92-kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure. J. Biol. Chem. 266:4514-4520.
20. Muthuswamy, S.K., D. Li, S. Lelievre, M.J. Bissell, and J.S. Brugge. 2001. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3:785-792.
21. Noe, V., B. Fingleton, K. Jacobs, H.C. Crawford, S. Vermeulen, W. Steelant, E. Bruyneel, L.M. Matrisian, and M. Mareel. 2001. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 114:111-118.
22. Owens, D.W., V.G. Brunton, E.K. Parkinson, and M.C. Frame. 2000. E-cadherin at the cell periphery is a determinant of keratinocyte differentiation in vitro. Biochem. Biophys. Res. Commun. 269:369-376.
23. Penault-Llorca, F., F. Bertucci, J. Adelaide, P. Parc, F. Coulier, J. Jacquemier, D. Birnbaum, and O. deLapeyriere. 1995. Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer. 61:170-176.
24. Pintucci, G., P.J. Yu, R. Sharony, F.G. Baumann, F. Saponara, A. Frasca, A.C. Galloway, D. Moscatelli, and P. Mignatti. 2003. Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2-/-microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1/2). J. Cell. Biochem. 90:1015-1025.
25. Powers, C.J., S.W. McLeskey, and A. Wellstein. 2000. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer. 7:165-197.
26. Radisky, D., C. Hagios, and M.J. Bissell. 2001. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11:87-95.
27. Radisky, D.C., D.D. Lery, L.E. Littlepape, H. Liu, C.M. Nelson, J.E. Fata, D. Leake, E.L. Godden, D.G. Albertson, M.A. Nieto, et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 436:123-127.
28. Scheid, M.P., and J.R. Woodgett. 2001. Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia. 6:83-99.
29. Schmeichel, K.L., and M.J. Bissell. 2003. Modeling tissue-specific signaling and organ function in three dimensions. J. Cell Sci. 116:2377-2388.
30. Seton-Rogers, S.E., Y. Lu, L.M. Hines, M. Koundinya, J. LaBaer, S.K. Muthuswamy, and J.S. Brugge. 2004. Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. USA. 101:1257-1262.
31. Shaw, K.R., C.N. Wrobel, and J.S. Brugge. 2004. Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J. Mammary Gland Biol. Neoplasia. 9:297-310.
32. Sternlicht, M.D., A. Lochter, C.J. Sympson, B. Huey, J.P. Rougier, J.W. Gray, D. Pinkel, M.J. Bissell, and Z. Werb. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:137-146.
33. Thompson, E.W., J. Torri, M. Sabol, C.L. Sommers, S. Byers, E.M. Valverius, G.R. Martin, M.E. Lippman, M.R. Stampfer, and R.B. Dickson. 1994. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin. Exp. Metastasis. 12:181-194.
34. Welm, B.E., K.W. Freeman, M. Chen, A. Contreras, D.M. Spencer, and J.M. Rosen. 2002. Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J. Cell Biol. 157:703-714.
35. Wong, A., B. Lamothe, A. Lee, J. Schlessinger, and I. Lax. 2002. FRS2 attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase cbl. Proc. Natl. Acad. Sci. USA. 99:6684-6689.
36. Wrobel, C.N., J. Debnath, E. Lin, S. Beausoleil, M.F. Roussel, and J.S. Brugge. 2004. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J. Cell Biol. 165:263-273.
37. Xu, X., C. Li, K. Takahashi, H.C. Slavkin, L. Shum, and C.X. Deng. 1999. Murine fibroblast growth factor receptor 1alpha isoforms mediate node regression and are essential for posterior mesoderm development. Dev. Biol. 208:293-306.
38. Yang, J., S.A. Mani, J.L. Donaher, S. Ramaswamy, R.A. Itzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R.A. Weinberg. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117:927-939.
39. Yuen, T., W. Zhang, B.J. Ebersole, and S.C. Sealfon. 2002. Monitoring G-proteincoupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol. 345:556-569.